NCT00505154View on ClinicalTrials.gov

Effect of Rosuvastatin on Left Ventricular Remodeling

PHASE3CompletedINTERVENTIONAL
Enrollment

75

Participants

Timeline

Start Date

July 31, 2007

Primary Completion Date

July 31, 2013

Study Completion Date

July 31, 2013

Conditions
Dilated Cardiomyopathy
Interventions
DRUG

Rosuvastatin

Rosuvastatin 10 mg tablets od for 6 months

DRUG

placebo

placebo

Trial Locations (1)

Unknown

Oslo University Hospital, Oslo

All Listed Sponsors
lead

Oslo University Hospital

OTHER

NCT00505154 - Effect of Rosuvastatin on Left Ventricular Remodeling | Biotech Hunter | Biotech Hunter